Ticker
PALICompany Name
PALISADE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 6.75M | $ 4.08M | $ -348K | $ 0 | -55.24% |
3/31/2025 | $ 3.69M | $ 7.7M | $ -348K | $ 0 | -199.22% |
12/31/2024 | $ 3.08M | $ 10.38M | $ -426K | $ 0 | -322.84% |
9/30/2024 | $ 3.16M | $ 6.03M | $ -371K | $ 0 | -178.68% |
6/30/2024 | $ 4.34M | $ 7.82M | $ -411K | $ 0 | -170.81% |
3/31/2024 | $ 5.83M | $ 9.55M | $ -461K | $ 0 | -155.89% |
12/31/2023 | $ 4.76M | $ 11.58M | $ -391K | $ 0 | -234.95% |
9/30/2023 | $ 4.79M | $ 11.32M | $ -556K | $ 0 | -224.5% |
6/30/2023 | $ 4.73M | $ 21.9M | $ -668K | $ 0 | -448.88% |
3/31/2023 | $ 10.85M | $ 18.3M | $ -791K | $ 0 | -161.41% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for PALISADE BIO INC is calculated as follows: (-1 * CF - Equity [ $ 14.7M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -369.13K ]) / Market Cap [ $ 9.77M ]
(=) Shareholder Yield [ -146.63% ]
Minimum
Jun 30, 2023
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |